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ST]MMÀRY
In  man the g lomerular  f i l t ra t ion rate (CFR) r j -ses dur ing
pregnancy. An increased GFR also can be found during the use of a
high protein diet cotnpared with a low protein diet. Both
observations indicate that in man a reserve fi l tration capacity
is  avaiLable.  Àn even more convinc ing ev idence for  th is
supposition is the fact that after kidney donation GFR roughly
amounts to 70 per  cent  of  the pre-donat ion cFR. The lat ter  a lso
indicates that  a loss of  g lonerul i  can be compensated for  by
hyperfi ltration of the remnant gloneruli. However, in rats it has
been found that compensatory hyperfi ltration, for instance
induced by subtotal nephrectorny, leads to a progressively
downhil l course of the renal function and the development of
prote inur ia,  both of  which can be anel iorated by a prote in-
restr ic ted d iet .  Recent ly ,  we have demonstrated that  prote in
restriction also slows down the progression towards end-stage
renal failure in patients with moderate to severe renal
insuf f ic iency.  This may indicate that  i tharmful  g lomerular
hyperf i l t ra t iont t  can ex is t  in  man too.  Therefore,  wê have
invest igated whether  reserve f i l t ra t ion capaci ty  ( i .e .  the
absence of  g lornerular  hyperf i l t ra t ion)  can be measured in
pat ients wi th renal  d isease by rnanipulat ion of  the GFR. For  the
latter purpose we have used the infusion of low-dose dopamine and
the infus ion of  amino acids,  separate ly  or  s imul taneously
adminis tered.
Subpharnacological doses of dopanine (L-2 pg/kg/mín), an
endogenous catecholarnine, cause renal vasodilatation mediated by
speci f ic  doparninerg ic  receptors.  This resul ts  in  an increased
renal  b lood f low and GFR. Thus,  we have used the in fus ion of
dopanine at  a rate of  1.5-2.O pq/kg/min in  order  to increase GFR.
Firs t ly ,  th is  has been done in 32 pat ients wi th fgA g lomerulo-
pathy (chapter  2) .  fn  these pat ients the in fus ion of  low-dose
dopanine does not  af fect  ef fect ive renal  p lasma f low (ERPF) and
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cFR i f  basel ine GFR amounts to 73 n l lmin/L.73 m2 or  less.  Above
th is  leve1 the dopamine- induced increase in GFR is  c losely
reLated to the basel ine GFR, i .e .  a larger  r ise in  GFR occurs
wi th increasing basel ine GFR. Because of  a substant ia l  larger
r ise in  ef fect ive renal  p lasrna f low (ERPF) than in GFR, the
f i l t ra t ion f ract ion (FF=GFR:ERPF) fa11s.  This can be expla ined by
a predominant doparnine-induced diLatation of the efferent
ar ter io le.  However,  a dopamine- induced shi f t  in  renal  b lood f low
to nephrons of the inner cortex with a 1ow FF rnay attribute to
this fall in FF a1so. It is consluded that in IgA glomerulopathy
nephron loss is  cornpensated for  by a progressive ut i l izat ion of
reserve fi l tration capacity which seems to be exhausted when
compensa ted  cFR fa I1s  be low  73  n l / n i n /1 .73  m2 .
In chapter 3 those observations are extended to patients with
other renal diseases, healthy individuals after uninephrectomy
and healthy control subjects. once agaÍn it is demonstrated that
the doparnine-induced rise in GFR increases with increasing
basel ine cFR and thaÈ cFR cannot  be increased i f  basel ine cFR
falls below 50 rnlruninrzl .73 m2. The doparnine-induced changes in
ERPF and cFR of healthy volunteers are significantly higher than
doparnine-induced changes in ERPF and cFR of healthy individuals
after uninephrectony as well as of renal patients with a norrnal
basel ine cFR. Therefore,  i t  is  concluded that  a l ready ear ly  in
renal  d isease there ex is ts  a d i rn in ished reserve f i l t ra t ion
capacity. During the infusion of low-dose doparnine heart rate is
unaf fected whereas nean ar ter ia l  pressure decreases s l ight ly .
Ur ine volume and natr iures is  increase.
Both infusion of amino acids and a neal of meat are well-
known to increase cFR. Therefore, we also have used the infusion
of an amino acid solution lvanin\1 in order to affect GFR
(chapter  4) .  fn  heal thy volunteers an increase in GFR is  found.
Hohrever, patients with rnoderate to severe renal insufficiency do
not respond to the infusion of arnino acids. Unlike during
doparnine infusion, the FF tends to increase during arnino acid
infusj.on. This is in accord with the hypothesis of Alvestrand and
Bergstrtlm that amino acids affect GFR by the induction of
1 0 9
afferent vasodilatation thus increasing net uLtrafi ltration
pressure.
Since dopanine infusion and anino acid infusion appear to
affect cFR in different ways, ne also have investigated the
effect of the conbined infusion of these agents on the GFR
(chapter 5). fndeed we have been able to denonstrate that
dopamJ-ne and amino acids lrere additive with respect to their
effect on GFR. The highest values for cFR are found during the
conbined infusion in healthy volunteers. In patients with
moderate to severe renal impairment no significant changes in cFR
could be found which rnay point to the existence of glomerular
hyperfi ltration in these patients.
In patients with Type I (= insulin-dependent) diabetes
nell itus a supernormal cFR can be found. This usually is
attributed to an enlarged kidney slze with increased glomerular
surface area and/or a decreased renal vascular resistance. To
investigate whether the supernormal cFR in Type L diabetlc
patients is based on a predoninant dilatatLon of the efferent
arterioler 9rê have investigated the effect of low-dose dopamine
on renal haemodynamics of 12 well-regulated patients with this
disease (chapter 6). The dopanine-induced changes in renal
haemodynamics dtd not differ between these patients and healthy
volunteers. Therefore, Ire have concluded that the supernorrnal cFR
in Type I diabetic patients is not caused by a predominant
efferent vasodilatation. This is in accord with a recent
hypothesis which assumes that th9 increased GFR after protein
ingestion as well as the supernornal GFR in Tlpe I diabetic
patients are based on afferent vasoditatation which is induced by
a liver-derived substance. Thus, we also have investigated the
effect of the administration of amino acids on cFR of satisfac-
tory controlled Type 1 diabetic patients (chapter 7). It ls
concluded that diabetic patients nay be subdivided in two groups.
Firstly, a group of patients with a nornal. GFR who possess a
normal renal reserve fi l tration capacity, i.e. an anino acid- and
dopamine-induced increase in cFR not dlfferent fron healthy
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which is caused by dilatation of the afferent arteriole since
amino acid infusion does not affect GFR in these patients
wherease dopanine infusion increases GFR to the sane extent as
healthy subjects.
In the general discussion it is suggested that it nakes nore
sense to subdivide the so-called I 'glomerular hyperfi ltrationil in
glomerular hyperperfusion and in glomerular hypertension,
especially sor as the latter seems to be the harmful factor.
Furthermore, studies warranted and possible treatment strategies
are provided for both patients with renal disease and patients
with Type l- diabets melLitus with or without nephropahty.
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